Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2024 Jan 25.

Published in final edited form as: Mol Cell Biochem. 2020 Jan 7;466(1-2):1–15. doi: 10.1007/s11010-019-03680-y

Fig. 3 — Both cells, MCs (a) and MGECs (b) were treated with or without Ang-II for 48 h. GYY (GYY4137) was added 1 h prior to the Ang-II treatment. Cells were immunostained against MMP-14 (green) and nuclei counterstained with DAPI (blue). (c) and (d) summarized data of MMP-14 expression in MCs and MGECs, respectively. Data are presented as mean ± SEM, n=9 independent experiments / group. *p <0.05 vs control, †p <0.05 vs Ang-II. Scale bar, 20 μm; magnification 60X.

Fig. 3 — Both cells, MCs (a) and MGECs (b) were treated with or without Ang-II for 48 h. GYY (GYY4137) was added 1 h prior to the Ang-II treatment. Cells were immunostained against MMP-14 (green) and nuclei counterstained with DAPI (blue). (c) and (d) summarized data of MMP-14 expression in MCs and MGECs, respectively. Data are presented as mean ± SEM, n=9 independent experiments / group. *p <0.05 vs control, †p <0.05 vs Ang-II. Scale bar, 20 μm; magnification 60X.